Comprehensive bioinformatics analysis of integrator complex subunits: expression patterns, immune infiltration, and prognostic signature, validated through experimental approaches in hepatocellular carcinoma

被引:0
|
作者
Xu, Yifei [1 ]
Liao, Wenlian [1 ]
Wang, Ting [1 ]
Zhang, Liwei [2 ]
Zhang, Hui [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai 201203, Peoples R China
[2] Xiamen Univ, Xiangan Hosp Xiamen Univ, Sch Med, Dept Anesthesiol, Xiamen 361101, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
INTSs; HCC; Diagnosis; Prognosis; Immune infiltration; Bioinformatics analysis; GENE-EXPRESSION; IDENTIFICATION; TRANSCRIPTION; DICE1;
D O I
10.1007/s12672-024-01118-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundHepatocellular carcinoma (HCC) is a common gastrointestinal malignancy with a high incidence and poor prognosis. The subunits of the integrator complex (INTS1-14) play a crucial role in regulating genes dependent on RNA Polymerase II, which may be associated with cancer. However, the role of INTSs in HCC remains unclear. This study aims to comprehensively analyze the clinical value and potential role of INTS family genes in HCC through systematic bioinformatics analysis.MethodsWe employed various public databases, including UALCAN, HPA, Kaplan-Meier Plotter, GEPIA2, TNMplot, STRING, TIMER, and TISIDB, to investigate the expression levels, clinicopathological correlations, diagnostic and prognostic value, genetic alterations, co-expression network, molecular targets, and immune infiltration of INTSs in HCC. Additionally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were utilized to investigate the biological functions of genes associated with INTSs. Furthermore, Western blot, real-time fluorescence quantitative reverse transcription polymerase chain reaction (RT-qPCR), and immunohistochemistry techniques were employed to assess the expression of relevant proteins and genes. The proliferation of HCC cells was evaluated using the CCK8 assay.ResultsWe found that in HCC, there was a significant upregulation of INTSs at the transcriptional level, particularly INTS1, INTS4, INTS7, and INTS8. Additionally, the protein levels of INTS1 and INTS8 were notably elevated. The overexpression of these INTSs was strongly correlated with tumor stages in HCC patients. INTS1, INTS4, INTS7, and INTS8 exhibited significant diagnostic and prognostic value in HCC. Moreover, their expression was associated with immune infiltrations and activated status, including B cells, CD8 + T cells, CD4 + T cells, NK cells, macrophages, and dendritic cells. Functional predictions indicated that INTS1, INTS4, INTS7, and INTS8 were involved in various cancer-related signaling pathways, such as TRAIL, IFN-gamma, mTOR, CDC42, Apoptosis, and the p53 pathway. Furthermore, we observed a significant upregulation of INTS1, INTS4, INTS7, and INTS8 expression in HCC cell lines compared to normal liver cell lines. The level of INTS1 protein was higher in cancerous tissues compared to adjacent non-cancerous tissues (n = 16), and the suppression of INTS1 resulted in a significant decrease in the proliferation of Huh7 cells.ConclusionThese findings indicate the potential of INTS family genes as diagnostic biomarkers and therapeutic targets in HCC. Further research is needed to understand the underlying mechanisms and explore clinical applications.
引用
收藏
页数:19
相关论文
共 49 条
  • [1] A Novel Prognostic Immune-related Gene Signature in Hepatocellular Carcinoma Through Bioinformatics and Experimental Approaches
    Pourbagheri-Sigaroodi, Atieh
    Momeny, Majid
    Rezaei, Nima
    Fallah, Fatemeh
    Bashash, Davood
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2024, 23 (06) : 699 - 726
  • [2] Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma
    Wang, Xiaofei
    Qiao, Jie
    Wang, Rongqi
    BIOSCIENCE REPORTS, 2020, 40
  • [3] Comprehensive analysis of prognostic value and immune infiltration of IAPs family in hepatocellular carcinoma
    Yang, Xuejie
    Yu, Xiaoqian
    Nie, Hui
    Jiang, Wenying
    Zhou, Jianhua
    Ou, Chunlin
    He, Xiaoyun
    JOURNAL OF CANCER, 2023, 14 (15): : 2848 - 2866
  • [4] Construction of a ceRNA network in hepatocellular carcinoma and comprehensive analysis of immune infiltration patterns
    Zuo, Zhifan
    Chen, Tingsong
    Zhang, Yue
    Han, Lei
    Liu, Bo
    Yang, Bin
    Han, Tao
    Zheng, Zhendong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (12): : 13356 - 13379
  • [5] The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma
    Peng, Bi
    Yan, Yuanliang
    Xu, Zhijie
    PEERJ, 2021, 9
  • [6] A novel immune-associated prognostic signature based on the immune cell infiltration analysis for hepatocellular carcinoma
    Lin, Xinrong
    Tian, Chuan
    Pan, Fan
    Wang, Rui
    ONCOLOGIE, 2024, 26 (01) : 91 - 103
  • [7] Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma
    Yao, Dingjin
    Deng, Yiran
    Zhang, Si
    Liang, Limiao
    Zhang, Li
    Weng, Shuqiang
    Chen, She
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (05):
  • [8] Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma
    Sun, Liang
    Yu, Shian
    Dong, Cairong
    Wu, Zhengyi
    Huang, He
    Chen, Zhendong
    Wu, Zhipeng
    Yin, Xiangbao
    FRONTIERS IN GENETICS, 2022, 13
  • [9] Integrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma
    Hu, Kuan
    Xu, Zhijie
    Yao, Lei
    Yan, Yuanliang
    Zhou, Lei
    Li, Juanni
    AGING-US, 2021, 13 (21): : 24117 - 24135
  • [10] Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma
    Wu, Zhengqiang
    Guo, Li
    Wan, Lijun
    Xu, Kedong
    Luo, Linfei
    Wen, Zhili
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 11891 - 11905